Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Racial disparity in the genomics of precision oncology of prostate cancer. | Cancer Rep (Hoboken) | 2023 | 37565547 | PubTator, text mining | PubMed |
| Fance deficiency inhibits primordial germ cell proliferation associated with transcription-replication conflicts accumulate and DNA repair defects. | J Ovarian Res | 2023 | 37563658 | PubTator, text mining | PubMed |
| FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair. | Sci Adv | 2023 | 37556550 | PubTator, text mining | PubMed |
| BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. | EBioMedicine | 2023 | 37549632 | PubTator, text mining | PubMed |
| A self-repair history: compensatory effect of a de novo variant on the FANCA c.2778+83C>G splicing mutation. | Front Genet | 2023 | 37547463 | PubTator, text mining | PubMed |
| Clinical and genetic characteristics in lymphoma patients with a second solid malignancy. | Front Oncol | 2023 | 37546421 | PubTator, text mining | PubMed |
| Cell-free DNA in the management of prostate cancer: Current status and future prospective. | Asian J Urol | 2023 | 37538150 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. | J Med Genet | 2023 | 37536918 | PubTator, text mining | PubMed |
| Efficient separation of phycocyanin of Nostoc commune by multistep diafiltration using ultra-filtration membrane modules. | Bioprocess Biosyst Eng | 2023 | 37532892 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of DNA damage repair in germ cell development. | Front Endocrinol (Lausanne) | 2023 | 37529603 | PubTator, text mining | PubMed |
| Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. | Front Pediatr | 2023 | 37528877 | PubTator, text mining | PubMed |
| Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer. | World J Urol | 2023 | 37528288 | PubTator, text mining | PubMed |
| A Clinical Conundrum with Diagnostic and Therapeutic Challenge: a Tale of Two Disorders in One Case. | J Clin Immunol | 2023 | 37526892 | PubTator, text mining | PubMed |
| FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability. | Nucleic Acids Res | 2023 | 37526271 | PubTator, text mining | PubMed |
| Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers. | JAMA Netw Open | 2023 | 37523182 | PubTator, text mining | PubMed |
| MAVS Antagonizes Human Stem Cell Senescence as a Mitochondrial Stabilizer. | Research (Wash D C) | 2023 | 37521327 | PubTator, text mining | PubMed |
| DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology. | Int J Mol Sci | 2023 | 37511177 | PubTator, text mining | PubMed |
| LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy. | Biomedicines | 2023 | 37509517 | PubTator, text mining | PubMed |
| Landscape of Genetic Mutations in Appendiceal Cancers. | Cancers (Basel) | 2023 | 37509254 | PubTator, text mining | PubMed |
| Germline Determinants of Esophageal Adenocarcinoma. | Gastroenterology | 2023 | 37507074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=20